Pharmacoeconomic analysis of antidepressants for major depressive disorder in the United Kingdom.
- 1 August 2000
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 18 (2) , 143-148
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: A meta-analysis of randomized controlled trialsClinical Therapeutics, 1999
- Pharmacoeconomic Analysis of Venlafaxine in the Treatment of Major Depressive DisorderPharmacoEconomics, 1997
- Depression in the community: the first pan-European study DEPRES (Depression Research in European Society).1997
- The National Psychiatric Morbidity Surveys of Great Britain – initial findings from the Household SurveyPsychological Medicine, 1997
- Depression in the communityInternational Clinical Psychopharmacology, 1997
- Rank-order Stability Analysis (ROSA)Medical Decision Making, 1995
- A Markov Process Analysis Comparing the Cost Effectiveness of Maintenance Therapy with Citalopram versus Standard Therapy in Major DepressionPharmacoEconomics, 1995
- What Price Depression?The British Journal of Psychiatry, 1994
- The costs of depressionInternational Clinical Psychopharmacology, 1993